Updates are available Correction dated 2024-10-19
Click to view Correction: https://doi.org/10.1007/s10456-024-09952-6
-
Authors
Yagi, Hitomi
Boeck, Myriam
Nian, Shen
Neilsen, Katherine
Wang, Chaomei
Lee, Jeff
Zeng, Yan
Grumbine, Matthew
Sweet, Ian R.
Kasai, Taku
Negishi, Kazuno
Singh, Sasha A.
Aikawa, Masanori
Hellström, Ann
Smith, Lois E. H.
Fu, Zhongjie
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01 GM148741)
National Institutes of Health (R01HL126901)
Kowa Company Ltd
National Institute of Health (R01EY017017)
National Institute of Health (R01EY032492)
Boston Children's Hospital (1U54HD090255)
Boston Children's Hospital (97906)
Mass Lions Eye Foundation (73735)
Mass Lions Eye Foundation (77426)
- License Information
-
More Information
Article History
Received: 24 April 2024
Accepted: 22 July 2024
First Online: 3 August 2024
Change Date: 20 October 2024
Change Type: Update
Change Details: Supplementary information file was updated.
Change Date: 19 October 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10456-024-09952-6
Declarations
:
: IRS and MG have financial ties to EnTox Sciences (Mercer Island, WA), manufacturer of BaroFuse. All other authors declare no conflicts of interest.
